Paradigm Medical Ind Stock Performance

PDMI Stock  USD 0.0001  0.00  0.00%   
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Paradigm Medical are completely uncorrelated.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Paradigm Medical Ind has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong primary indicators, Paradigm Medical is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
  

Paradigm Medical Relative Risk vs. Return Landscape

If you would invest  0.01  in Paradigm Medical Ind on October 1, 2025 and sell it today you would earn a total of  0.00  from holding Paradigm Medical Ind or generate 0.0% return on investment over 90 days. Paradigm Medical Ind is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Paradigm, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Paradigm Medical Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Paradigm Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Paradigm Medical Ind, and traders can use it to determine the average amount a Paradigm Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
PDMI
Based on monthly moving average Paradigm Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Paradigm Medical by adding Paradigm Medical to a well-diversified portfolio.

Paradigm Medical Fundamentals Growth

Paradigm Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Paradigm Medical, and Paradigm Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Paradigm Pink Sheet performance.

About Paradigm Medical Performance

By evaluating Paradigm Medical's fundamental ratios, stakeholders can gain valuable insights into Paradigm Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Paradigm Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Paradigm Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company was founded in 1989 and is based in Salt Lake City, Utah. Paradigm Medical operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 5 people.

Things to note about Paradigm Medical Ind performance evaluation

Checking the ongoing alerts about Paradigm Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Paradigm Medical Ind help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Paradigm Medical Ind generated a negative expected return over the last 90 days
Paradigm Medical Ind has some characteristics of a very speculative penny stock
Paradigm Medical Ind currently holds 615 K in liabilities. Paradigm Medical Ind has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Paradigm Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Paradigm Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Paradigm Medical Ind sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Paradigm to invest in growth at high rates of return. When we think about Paradigm Medical's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 772 K. Net Loss for the year was (474 K) with profit before overhead, payroll, taxes, and interest of 525 K.
Paradigm Medical Ind currently holds about 21 K in cash with (74 K) of positive cash flow from operations.
Evaluating Paradigm Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Paradigm Medical's pink sheet performance include:
  • Analyzing Paradigm Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Paradigm Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Paradigm Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Paradigm Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Paradigm Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Paradigm Medical's pink sheet. These opinions can provide insight into Paradigm Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Paradigm Medical's pink sheet performance is not an exact science, and many factors can impact Paradigm Medical's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Paradigm Pink Sheet analysis

When running Paradigm Medical's price analysis, check to measure Paradigm Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Paradigm Medical is operating at the current time. Most of Paradigm Medical's value examination focuses on studying past and present price action to predict the probability of Paradigm Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Paradigm Medical's price. Additionally, you may evaluate how the addition of Paradigm Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Transaction History
View history of all your transactions and understand their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data